Zacks: Analysts Anticipate Safeguard Scientifics, Inc (NYSE:SFE) to Announce -$0.39 EPS

Equities analysts expect Safeguard Scientifics, Inc (NYSE:SFE) to post earnings of ($0.39) per share for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for Safeguard Scientifics’ earnings. Safeguard Scientifics reported earnings of ($0.81) per share during the same quarter last year, which suggests a positive year over year growth rate of 51.9%. The business is scheduled to report its next earnings results on Thursday, February 27th.

On average, analysts expect that Safeguard Scientifics will report full year earnings of $2.29 per share for the current financial year. For the next fiscal year, analysts forecast that the company will report earnings of ($1.31) per share. Zacks’ earnings per share calculations are an average based on a survey of research analysts that that provide coverage for Safeguard Scientifics.

Safeguard Scientifics (NYSE:SFE) last posted its quarterly earnings results on Thursday, November 7th. The asset manager reported ($0.12) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.56) by $0.44.

SFE has been the topic of a number of recent analyst reports. ValuEngine raised shares of Safeguard Scientifics from a “strong sell” rating to a “sell” rating in a report on Thursday, August 8th. Zacks Investment Research raised shares of Safeguard Scientifics from a “hold” rating to a “strong-buy” rating and set a $14.00 target price on the stock in a report on Tuesday, November 12th.

Institutional investors and hedge funds have recently modified their holdings of the company. NJ State Employees Deferred Compensation Plan raised its holdings in shares of Safeguard Scientifics by 4.6% during the 2nd quarter. NJ State Employees Deferred Compensation Plan now owns 22,833 shares of the asset manager’s stock valued at $275,000 after buying an additional 1,000 shares in the last quarter. Bank of Montreal Can raised its stake in shares of Safeguard Scientifics by 0.3% during the second quarter. Bank of Montreal Can now owns 516,582 shares of the asset manager’s stock worth $6,235,000 after acquiring an additional 1,637 shares in the last quarter. Captrust Financial Advisors lifted its holdings in shares of Safeguard Scientifics by 272.3% in the 2nd quarter. Captrust Financial Advisors now owns 3,008 shares of the asset manager’s stock worth $36,000 after acquiring an additional 2,200 shares during the last quarter. Morgan Stanley lifted its holdings in shares of Safeguard Scientifics by 15.2% in the 2nd quarter. Morgan Stanley now owns 19,979 shares of the asset manager’s stock worth $241,000 after acquiring an additional 2,630 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of Safeguard Scientifics by 3.1% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 116,664 shares of the asset manager’s stock valued at $1,409,000 after purchasing an additional 3,520 shares in the last quarter. Hedge funds and other institutional investors own 67.86% of the company’s stock.

NYSE SFE traded up $0.08 during trading hours on Friday, hitting $11.54. The company had a trading volume of 1,016 shares, compared to its average volume of 62,251. The company has a debt-to-equity ratio of 0.02, a quick ratio of 13.03 and a current ratio of 13.03. The firm has a market capitalization of $237.06 million, a price-to-earnings ratio of -15.17 and a beta of 0.84. Safeguard Scientifics has a 52 week low of $7.99 and a 52 week high of $12.91. The firm has a 50 day simple moving average of $11.47 and a 200 day simple moving average of $11.80.

Safeguard Scientifics Company Profile

Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round.

Further Reading: Cost of Equity For A Business, Investors

Get a free copy of the Zacks research report on Safeguard Scientifics (SFE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Safeguard Scientifics (NYSE:SFE)

Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.